Loading…
GlucoTrack, Inc. is projected to rise to $0.4383 by 2027, a +6% move from its current price of $0.4149. GCTK is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/4/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 5 | $0.3641 | $0.4147 | $0.4722 | -0.06% |
| Aug 6 | $0.3448 | $0.4144 | $0.498 | -0.12% |
| Aug 7 | $0.3307 | $0.4142 | $0.5187 | -0.18% |
| Aug 8 | $0.3192 | $0.4139 | $0.5367 | -0.24% |
| Aug 9 | $0.3094 | $0.4137 | $0.5531 | -0.30% |
| Aug 10 | $0.3007 | $0.4134 | $0.5683 | -0.36% |
| Aug 11 | $0.293 | $0.4132 | $0.5827 | -0.42% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.293 | $0.4132 | $0.5827 | -0.42% |
| Week 2 | $0.253 | $0.4114 | $0.669 | -0.83% |
| Week 3 | $0.2259 | $0.4097 | $0.7431 | -1.25% |
| Week 4 | $0.2052 | $0.408 | $0.8114 | -1.66% |
| Week 5 | $0.1884 | $0.4063 | $0.8764 | -2.07% |
| Week 6 | $0.1743 | $0.4046 | $0.9391 | -2.48% |
| Week 7 | $0.1623 | $0.4029 | $1.00 | -2.89% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
GlucoTrack, Inc. is a medical device company focused on the development of an implantable continuous blood glucose monitor (CBGM) for people with diabetes in the United States. The GlucoTrack CBGM is a long-term implantable blood-based monitor for use by Type 1 diabetes patients and insulin-dependent Type 2 diabetes patients.
The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021. GlucoTrack was founded in 2001 and is based in Rutherford, New Jersey.
GlucoTrack operates in the Healthcare sector, delivering a medical device solution for diabetes management. The description highlights its focus on implantable monitoring technology designed for chronic use by patients with diabetes, within the United States healthcare landscape.
GlucoTrack trades under the symbol GCTK and currently trades at $0.477. Its market capitalization stands at $3.68M, and it ranks 5347 in market size.
The current technical picture is bullish, with RSI(14) at 50, the 50-day simple moving average at $0.4453 and the 200-day simple moving average at $2.45. Nearby support is at $0.285 and resistance is at $0.78.
The 30-day price range runs from $0.2026 to $1.12, and annualized volatility is 200%. Looking ahead, the year-by-year forecasts show gradual upside with a range of min/avg/max values and ROI figures across years, including a notable rise in the later years.
A major floor 95.4% below — a decisive break under it would weaken the trend.
The nearest floor, 31.3% below — buyers have tended to step in here.
The nearest ceiling, 88.0% above — a clean break opens room to run.
A major ceiling 162.7% above — clearing it would confirm fresh momentum.
Key GCTK support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of GCTK market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.4292 | Sell | $0.4689 | Sell |
| MA 10 | $0.3839 | Buy | $0.4291 | Sell |
| MA 20 | $0.4101 | Buy | $0.4153 | Sell |
| MA 50 | $0.4453 | Sell | $0.5023 | Sell |
| MA 100 | $0.6518 | Sell | $1.52 | Sell |
| MA 200 | $2.45 | Sell | $39.37 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 52.78 | Neutral |
| Stoch RSI (14) | 47.21 | Neutral |
| CCI (20) | 49.15 | Neutral |
| Williams %R (14) | -61.21 | Info |
| MACD (12,26,9) | 0.02 | Buy |
| ROC (12) | -9.83 | Sell |
| Bollinger %B (20,2) | 0.64 | Neutral |
| Stochastic %K (14) | 38.79 | Neutral |
| TRIX (15) | -0.57 | Sell |
| Awesome (5,34) | 0.04 | Buy |
| Ultimate (7,14,28) | 56.44 | Neutral |
| Momentum (10) | -0.02 | Sell |
| Aroon Osc (25) | 4.00 | Buy |
| Hull MA (9) | 0.54 | Sell |
| ADX (14) | 25.87 | Buy |
| ATR (14) | 0.08 | Info |
The near-term setup reflects a bullish tilt in sentiment, supported by a neutral RSI reading of 50 and price action around the $0.48 area.
Key short-term levels include support at $0.285 and resistance at $0.78, with the 30-day range spanning from $0.2026 to $1.12. The SMA50 sits at $0.4453, suggesting near-term momentum is attempting to push price toward the resistance level.
If near-term dynamics shift, the price could test the support or break toward the resistance, but the current structure remains bounded by the listed levels for the coming weeks.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.285 | $0.4149 | $0.5607 | 0% | Neutral | |
| $0.3194 | $0.4383 | $0.6499 | +6% | Neutral | |
| $0.3522 | $0.5141 | $0.8136 | +24% | Bullish | |
| $0.3829 | $0.589 | $0.9792 | +42% | Bullish | |
| $0.4119 | $0.6643 | $1.15 | +60% | Bullish | |
| $0.3642 | $0.6141 | $1.10 | +48% | Bullish | |
| $0.3129 | $0.5503 | $1.02 | +33% | Bullish | |
| $0.2953 | $0.541 | $1.03 | +30% | Bullish | |
| $0.2544 | $0.4848 | $0.945 | +17% | Neutral | |
| $0.3632 | $0.7193 | $1.43 | +73% | Bullish | |
| $0.283 | $0.6289 | $1.38 | +52% | Bullish | |
| $0.7605 | $1.69 | $3.89 | +307% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $0.285 | $0.4149 | $0.508 | +0.00% |
| September 2026 | $0.3471 | $0.4219 | $0.535 | +1.68% |
| October 2026 | $0.3188 | $0.3929 | $0.5084 | -6.88% |
| November 2026 | $0.3036 | $0.3785 | $0.4978 | -3.66% |
| December 2026 | $0.3336 | $0.4203 | $0.5607 | +11.03% |
Click any year to see its month-by-month GCTK forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, GCTK could reach as high as $0.5607, with a base case around $0.4149 and support toward $0.285 — roughly 0% from $0.4149. Price action looks broadly range-bound.
Expect GCTK to range from $0.3194 to $0.6499 through 2027. The $0.4383 average target implies a +6% move from current prices. That is up +6% on the projected 2026 average. A consolidation phase looks the most probable path here.
The GCTK price prediction for 2028 points to an average of $0.5141 (low $0.3522, high $0.8136) — a potential gain of +24% on today's $0.4149. Momentum favours further upside here.
In 2029, GCTK is projected to trade between $0.3829 and $0.9792, averaging $0.589 — a potential gain of +42% from today's $0.4149. That is up +15% on the projected 2028 average. Buyers look set to stay in control over this stretch.
GlucoTrack, Inc.'s 2030 outlook centres on $0.6643, within a $0.4119 to $1.15 range. That is up +13% on the projected 2029 average. That marks a +60% change versus current levels. Momentum favours further upside here.
By 2031, GCTK could reach as high as $1.10, with a base case around $0.6141 and support toward $0.3642 — roughly +48% from $0.4149. Buyers look set to stay in control over this stretch.
Expect GCTK to range from $0.3129 to $1.02 through 2032. The $0.5503 average target implies a +33% move from current prices. That is -10% versus the projected 2031 average. Momentum favours further upside here.
The GCTK price prediction for 2033 points to an average of $0.541 (low $0.2953, high $1.03) — a potential gain of +30% on today's $0.4149. Buyers look set to stay in control over this stretch.
In 2034, GCTK is projected to trade between $0.2544 and $0.945, averaging $0.4848 — a potential gain of +17% from today's $0.4149. That is -10% versus the projected 2033 average. Price action looks broadly range-bound.
GlucoTrack, Inc.'s 2035 outlook centres on $0.7193, within a $0.3632 to $1.43 range. That is up +48% on the projected 2034 average. That marks a +73% change versus current levels. Buyers look set to stay in control over this stretch.
By 2040, GCTK could reach as high as $1.38, with a base case around $0.6289 and support toward $0.283 — roughly +52% from $0.4149. Momentum favours further upside here.
Expect GCTK to range from $0.7605 to $3.89 through 2050. The $1.69 average target implies a +307% move from current prices. That is up +169% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in GCTK today (≈ 2,410.21933 GCTK) could be worth
$4,073.16
+$3,073.16 (+307%) by 2050 · US Dollar
Based on the average projected GCTK price of $1.69 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in GCTKwould be worth at today's price.
$1,000 invested in GCTK on Jul 31, 2025 (≈ 162.601623 GCTK) would be worth
$67.46
-$932.54 (-93.3%) today · 0.07× · US Dollar
Based on a GCTK entry price of $6.15 vs. today's $0.4149.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.291 | $1,425.77 | +42.6% |
| 1 month ago | $0.348 | $1,192.24 | +19.2% |
| 3 months ago | $0.8 | $518.62 | -48.1% |
| 6 months ago | $1.96 | $211.68 | -78.8% |
| 1 year ago | $6.15 | $67.46 | -93.3% |
| All time (5.0y) ago | $37,362 | $0.01 | -100.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our GCTK forecast.
Our base-case forecast reaches $0.83 around 2050.
Implied market cap at $0.83: $6.41M
The multi-year forecast shows growing upside through 2030 and beyond, with the following reference points: 2026 avg $0.477, min $0.285, max $0.6473 and ROI 0% (sentiment NEUTRAL); 2027 avg $0.5025, min $0.3661, max $0.7454 and ROI 5.3% (NEUTRAL); 2028 avg $0.5909, min $0.4048, max $0.9352 and ROI 23.9% (BULLISH); 2029 avg $0.6779, min $0.4407, max $1.13 and ROI 42.1% (BULLISH); 2030 avg $0.7616, min $0.4722, max $1.32 and ROI 59.7% (BULLISH).
Further out, 2035 shows avg $0.828 with a max of $1.65 and ROI 73.6% (BULLISH); 2040 avg $0.7223, min $0.325, max $1.58 and ROI 51.4% (BULLISH); and 2050 avg $1.95, min $0.8753, max $4.47 and ROI 307.8% (BULLISH).
These figures indicate a long-run bullish trajectory with higher potential upside in later years, but they are estimates and not guarantees. Drivers and risks are not detailed in the data, so the projections should be interpreted as informational guidance rather than assured outcomes.
Tap a question to reveal the answer.
The forecast shows min $0.4722, avg $0.7616, max $1.32; ROI 59.7%; sentiment BULLISH.
The forecast shows rising average prices in multiple years and positive ROI values such as 42.1% in 2029, 59.7% in 2030, and 307.8% in 2050; sentiment varies between NEUTRAL and BULLISH. These are estimates, not guarantees.
In the forecast, the max values reach $1.13 in 2029 and $1.32 in 2030, with higher tops such as $1.65 in 2035 and $4.47 in 2050.
Current price is $0.477 and market cap is $3.68M.
Annualized volatility is 200%.
GlucoTrack, Inc. Community Discussion
0Share your GlucoTrack, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.